Age

19–any

Sex

ALL

Healthy volunteers

Not accepted

Subjects who voluntarily signed informed consent for participating in this clinical study
Male and female over the age of 19
Hypertensive patients receiving two or more concomitant anti-hypertensive agents including fimasartan

Renal dialysis patients.
Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.
Severe renal disorder
Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
Medical history with hypersensitivity to Fimasartan
Pregnant women or lactating female.
Participate in another clinical trial.

Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study